Most Gut Microbes Can Be Cultured

Contrary to the popular thought that many species are “unculturable,” the majority of bacteria known to populate the human gut can be grown in the lab, scientists show.

Written byJyoti Madhusoodanan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

“Environmental C. difficile spores are highly transmissible for long periods after they are shed, commonly transmit within a local environment but also have the potential to spread rapidly over long distances,” the authors wrote in their paper.WIKIMEDIA, CJC2NDMicrobes thrive in nearly every Earthly environment, but surprisingly few are known to flourish when grown in labs. As a result, studies of the human gut microbiome have primarily utilized genomic approaches. By combining microbial culture experiments with genomic approaches, researchers from Wellcome Trust Sanger Institute and their colleagues have now shown that, contrary to the widely held assumption that most bacteria are “unculturable,” most known gut microbial species can be grown and preserved in vitro. The results, published today (May 4) in Nature, reveal that many “unculturable” gut bacteria belong to novel groups, and nearly 60 percent of them form spores in order to survive outside the human body.

“This is really an excellent study, it covers all the bases and makes an important contribution,” said James Oliver, a professor of microbiology at the University of North Carolina at Charlotte, who was not involved with the study.

To assess how much of the human gut microbiota could be cultured, the Sanger Institute’s Trevor Lawley and colleagues began with fresh fecal samples from six healthy individuals. The researchers sequenced the samples to identify bacterial diversity, grew bacteria from the samples on plates containing a broad-range growth medium called YCFA, and then compared the genomic data from the original samples to that from species that grew in the petri dishes. The two shared 72 percent of their genomic sequences, and sequences from the cultured bacterial colonies ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies